![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, September 16, 2022 7:31:45 AM
As we all know Dr Chandra was thrust into the role of becoming the face of ENZC, at least in social media circles. Prior to ENZC, he barely posted on Twitter. So I'm just saying I think in that instance, he was kinda put on the spot and probably was just sort of pacifying his audience, and he probably shouldn't have been talking or giving any information out about those studies. Same with the audited financials, should probably not have given the days/weeks comment, but I truly believe that was his belief at that time.
Bottom line for me MAGA, when I look at a lot of other OTC stocks, and try and see what the maximum potential is for their sp or mc, I really don't see anyone in the realm of what ENZC can deliver. Having Samsung Biologics alone as their CDMO, one of the largest in the world, as a OTC pink sheet co should speak volumes alone imo, you simply just don't see it. Clone 3 is where it's at, and that will take time obviously, but as they move through the process and trials, the value of this stock will definitely head higher.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM